Selected research
Industry Research
Haemodialysis Concentrates Industry Research Report 2026
Market perspective
The global Haemodialysis Concentrates market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Haemodialysis Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Haemodialysis Concentrates is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Haemodialysis Concentrates is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Haemodialysis Concentrates include B. Braun, Dialysis Medical Solutions, Fresenius Medical Care, MEDIVATORS, Nipro, Renacon Pharma, Rockwell Medical, Surni Group and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Haemodialysis Concentrates market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Haemodialysis Concentrates Market by Company
B. Braun
Dialysis Medical Solutions
Fresenius Medical Care
MEDIVATORS
Nipro
Renacon Pharma
Rockwell Medical
Surni Group
Baxter
BIOLIGHT
Weigao Group
Taishikang
Haemodialysis Concentrates Segment by Type
Bicarbonate Concentrates
Acid Concentrates
Haemodialysis Concentrates Segment by Application
Dialysis Center
Home Dialysis
Others
Haemodialysis Concentrates Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemodialysis Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Haemodialysis Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemodialysis Concentrates.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Haemodialysis Concentrates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Haemodialysis Concentrates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Haemodialysis Concentrates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bicarbonate Concentrates
- Acid Concentrates
Applications
- Dialysis Center
- Home Dialysis
- Others
Companies covered
- B. Braun
- Dialysis Medical Solutions
- Fresenius Medical Care
- MEDIVATORS
- Nipro
- Renacon Pharma
- Rockwell Medical
- Surni Group
- Baxter
- BIOLIGHT
- Weigao Group
- Taishikang
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Haemodialysis Concentrates Market Size (2021-2032)
- 2.2.2 Global Haemodialysis Concentrates Sales (2021-2032)
- 2.2.3 Global Haemodialysis Concentrates Market Average Price (2021-2032)
- 2.3 Haemodialysis Concentrates by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Bicarbonate Concentrates
- 2.3.3 Acid Concentrates
- 2.4 Haemodialysis Concentrates by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dialysis Center
- 2.4.3 Home Dialysis
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Haemodialysis Concentrates Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Haemodialysis Concentrates Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Haemodialysis Concentrates Revenue of Manufacturers (2021-2026)
- 3.4 Global Haemodialysis Concentrates Average Price by Manufacturers (2021-2026)
- 3.5 Global Haemodialysis Concentrates Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Haemodialysis Concentrates, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Haemodialysis Concentrates, Product Type & Application
- 3.8 Global Manufacturers of Haemodialysis Concentrates, Established Date
- 3.9 Global Haemodialysis Concentrates Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 B. Braun
- 4.1.1 B. Braun Company Information
- 4.1.2 B. Braun Business Overview
- 4.1.3 B. Braun Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 B. Braun Haemodialysis Concentrates Product Portfolio
- 4.1.5 B. Braun Recent Developments
- 4.2 Dialysis Medical Solutions
- 4.2.1 Dialysis Medical Solutions Company Information
- 4.2.2 Dialysis Medical Solutions Business Overview
- 4.2.3 Dialysis Medical Solutions Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dialysis Medical Solutions Haemodialysis Concentrates Product Portfolio
- 4.2.5 Dialysis Medical Solutions Recent Developments
- 4.3 Fresenius Medical Care
- 4.3.1 Fresenius Medical Care Company Information
- 4.3.2 Fresenius Medical Care Business Overview
- 4.3.3 Fresenius Medical Care Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fresenius Medical Care Haemodialysis Concentrates Product Portfolio
- 4.3.5 Fresenius Medical Care Recent Developments
- 4.4 MEDIVATORS
- 4.4.1 MEDIVATORS Company Information
- 4.4.2 MEDIVATORS Business Overview
- 4.4.3 MEDIVATORS Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 MEDIVATORS Haemodialysis Concentrates Product Portfolio
- 4.4.5 MEDIVATORS Recent Developments
- 4.5 Nipro
- 4.5.1 Nipro Company Information
- 4.5.2 Nipro Business Overview
- 4.5.3 Nipro Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nipro Haemodialysis Concentrates Product Portfolio
- 4.5.5 Nipro Recent Developments
- 4.6 Renacon Pharma
- 4.6.1 Renacon Pharma Company Information
- 4.6.2 Renacon Pharma Business Overview
- 4.6.3 Renacon Pharma Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Renacon Pharma Haemodialysis Concentrates Product Portfolio
- 4.6.5 Renacon Pharma Recent Developments
- 4.7 Rockwell Medical
- 4.7.1 Rockwell Medical Company Information
- 4.7.2 Rockwell Medical Business Overview
- 4.7.3 Rockwell Medical Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Rockwell Medical Haemodialysis Concentrates Product Portfolio
- 4.7.5 Rockwell Medical Recent Developments
- 4.8 Surni Group
- 4.8.1 Surni Group Company Information
- 4.8.2 Surni Group Business Overview
- 4.8.3 Surni Group Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Surni Group Haemodialysis Concentrates Product Portfolio
- 4.8.5 Surni Group Recent Developments
- 4.9 Baxter
- 4.9.1 Baxter Company Information
- 4.9.2 Baxter Business Overview
- 4.9.3 Baxter Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Baxter Haemodialysis Concentrates Product Portfolio
- 4.9.5 Baxter Recent Developments
- 4.10 BIOLIGHT
- 4.10.1 BIOLIGHT Company Information
- 4.10.2 BIOLIGHT Business Overview
- 4.10.3 BIOLIGHT Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 BIOLIGHT Haemodialysis Concentrates Product Portfolio
- 4.10.5 BIOLIGHT Recent Developments
- 4.11 Weigao Group
- 4.11.1 Weigao Group Company Information
- 4.11.2 Weigao Group Business Overview
- 4.11.3 Weigao Group Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Weigao Group Haemodialysis Concentrates Product Portfolio
- 4.11.5 Weigao Group Recent Developments
- 4.12 Taishikang
- 4.12.1 Taishikang Company Information
- 4.12.2 Taishikang Business Overview
- 4.12.3 Taishikang Haemodialysis Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Taishikang Haemodialysis Concentrates Product Portfolio
- 4.12.5 Taishikang Recent Developments
5 Global Haemodialysis Concentrates Market Scenario by Region
- 5.1 Global Haemodialysis Concentrates Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Haemodialysis Concentrates Sales by Region: 2021-2032
- 5.2.1 Global Haemodialysis Concentrates Sales by Region: 2021-2026
- 5.2.2 Global Haemodialysis Concentrates Sales by Region: 2027-2032
- 5.3 Global Haemodialysis Concentrates Revenue by Region: 2021-2032
- 5.3.1 Global Haemodialysis Concentrates Revenue by Region: 2021-2026
- 5.3.2 Global Haemodialysis Concentrates Revenue by Region: 2027-2032
- 5.4 North America Haemodialysis Concentrates Market Facts & Figures by Country
- 5.4.1 North America Haemodialysis Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Haemodialysis Concentrates Sales by Country (2021-2032)
- 5.4.3 North America Haemodialysis Concentrates Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Haemodialysis Concentrates Market Facts & Figures by Country
- 5.5.1 Europe Haemodialysis Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Haemodialysis Concentrates Sales by Country (2021-2032)
- 5.5.3 Europe Haemodialysis Concentrates Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Haemodialysis Concentrates Market Facts & Figures by Country
- 5.6.1 Asia Pacific Haemodialysis Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Haemodialysis Concentrates Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Haemodialysis Concentrates Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Haemodialysis Concentrates Market Facts & Figures by Country
- 5.7.1 South America Haemodialysis Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Haemodialysis Concentrates Sales by Country (2021-2032)
- 5.7.3 South America Haemodialysis Concentrates Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Haemodialysis Concentrates Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Haemodialysis Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Haemodialysis Concentrates Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Haemodialysis Concentrates Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Haemodialysis Concentrates Sales by Type (2021-2032)
- 6.1.1 Global Haemodialysis Concentrates Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Haemodialysis Concentrates Sales Market Share by Type (2021-2032)
- 6.2 Global Haemodialysis Concentrates Revenue by Type (2021-2032)
- 6.2.1 Global Haemodialysis Concentrates Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Haemodialysis Concentrates Revenue Market Share by Type (2021-2032)
- 6.3 Global Haemodialysis Concentrates Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Haemodialysis Concentrates Sales by Application (2021-2032)
- 7.1.1 Global Haemodialysis Concentrates Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Haemodialysis Concentrates Sales Market Share by Application (2021-2032)
- 7.2 Global Haemodialysis Concentrates Revenue by Application (2021-2032)
- 7.2.1 Global Haemodialysis Concentrates Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Haemodialysis Concentrates Revenue Market Share by Application (2021-2032)
- 7.3 Global Haemodialysis Concentrates Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Haemodialysis Concentrates Value Chain Analysis
- 8.1.1 Haemodialysis Concentrates Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Haemodialysis Concentrates Production Mode & Process
- 8.2 Haemodialysis Concentrates Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Haemodialysis Concentrates Distributors
- 8.2.3 Haemodialysis Concentrates Customers
9 Global Haemodialysis Concentrates Analyzing Market Dynamics
- 9.1 Haemodialysis Concentrates Industry Trends
- 9.2 Haemodialysis Concentrates Industry Drivers
- 9.3 Haemodialysis Concentrates Industry Opportunities and Challenges
- 9.4 Haemodialysis Concentrates Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst